Search For "cova"
1.4 million COVID-19 vaccine doses provided by US arrives in Afghanistan
Updated : 4 years, 8 months ago IST
Kabul [Afghanistan], July 9 (ANI): More than 1.4 million doses of the Johnson & Johnson COVID-19 vaccine arrived today in Afghanistan, the United Nations Children's Emergency Fund (UNICEF) said on Friday.
Read More
With a day of Covaxin stock left, Punjab CM calls for more supplies from C
Updated : 4 years, 8 months ago IST
Chandigarh (Punjab) [India], July 9 (ANI): Punjab Chief Minister Captain Amarinder Singh on Friday reiterated the need for an increase in COVID-19 vaccine supply from the Centre.
Read More
Union Minister Mansukh Mandaviya visits COVID-19 vaccine manufacturing fac
Updated : 4 years, 8 months ago IST
Ahmedabad (Gujarat) [India], July 4 (ANI): Union Minister of State for Chemicals and Fertilisers Mansukh Mandaviya on Sunday visited the COVID-19 vaccine manufacturing facilities of Zydus Cadila and Hester Biosciences in Gujarat.
Read More
Brazilian Supreme Court approves investigation of Bolsonaro over Covaxin d
Updated : 4 years, 8 months ago IST
Buenos Aires [Argentina], July 3 (ANI/Sputnik): The Supreme Federal Court of Brazil has approved a probe into President Jair Bolsonaro regarding alleged overpricing during the purchase of India's coronavirus vaccine Covaxin, the G1 website reported.
Read More
After release of Covaxin's phase 3 efficacy data, NTAGI chief says it will
Updated : 4 years, 8 months ago IST
New Delhi [India], (ANI): Hours after Bharat Biotech announced that its vaccine Covaxin's efficacy against COVID-19 is 77.8 per cent, National Technical Advisory Group on Immunisation (NTAGI) Chief Dr NK Arora said that these results will help the vaccine get recognition from the World Healt
Read More
Bharat Biotech releases Phase 3 trial results of Covaxin, claims vaccine e
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], July 3 (ANI): Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per cent effective against COVID-19.
Read More
Bangladesh receives first consignment of COVID-19 vaccine Moderna from US
Updated : 4 years, 8 months ago IST
Dhaka [Bangladesh], July 3 (ANI): Bangladesh received the first consignment of COVID-19 vaccine Moderna from the US on Friday through the COVAX initiative.
Read More
Congress says, why Centre 'conspicuously silent' on Covaxin pricing contro
Updated : 4 years, 8 months ago IST
New Delhi [India], July 3 (ANI): The Congress Party on Friday cornered the central government over the Covaxin pricing controversy in Brazil and asked the Centre why it is "conspicuously silent" on the matter.
Read More
Curtailed COVID-19 vaccination drive to resume at limited centres in Mumba
Updated : 4 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 2 (ANI): Amid a shortage of COVID-19 vaccine doses in the state, the vaccination drive in Mumbai will resume for three hours at a limited number of its centres, the Brihanmumbai Municipal Corporation (BMC) said on Friday.
Read More
COVAX calls for equal recognition of COVID-19 vaccines
Updated : 4 years, 8 months ago IST
New York [US], July 2 (ANI): COVAX, the global alliance for vaccine distribution, on Thursday urged governments around the world to recognize as fully vaccinated all people who have received COVID-19 vaccines that have been deemed safe and effective by the World Health Organization (WHO).
Read More
Switzerland, Iceland, 7 EU nations okay SII's Covishield vaccine, day afte
Updated : 4 years, 8 months ago IST
Zurich [Switzerland], July 1 (ANI): A day after external affairs minister S Jaishankar said he has taken up with European Union to accept COVID-19 vaccines, such as Covishield and Covaxin, for Indian nationals travelling to Europe, Switzerland, Iceland and seven European Union countries on T
Read More
'Submit results on Covavax adult trials first': Govt panel to SII on Covid
Updated : 4 years, 8 months ago IST
New Delhi [India], July 1 (ANI): An expert panel constituted by the government has recommended against granting permission to the Serum Institute of India (SII) to conduct phase two and three clinical trials of Covavax COVID-19 vaccine on children aged between 2-17 years, said sources on
Read More